Integrating Patient Preferences in Nonclinical Assessment of Immunomodulatory Therapies – Shifting the Paradigm
Immune-related adverse events (irAEs) are one of the leading causes affecting success rates of immunomodulatory …
General Project News
This category contains more general project news, including information about project meetings and events, stakeholder workshops and more broader online seminars, general project publications and much more.
ImSAVAR Cytokine Release Assay Webinar Sessions
Over two, well attended sessions in September 2021, the topic of cytokine release assays (CRA) …
Register to join the workshop
The upcoming imSAVAR Stakeholder Workshop: Integrating Patient Preferences in Nonclinical Assessment of Immunomodulatory Therapies – …
imSAVAR Stakeholder Survey: Views on Adverse Outcome Pathways & Model Grading Systems
The imSAVAR consortium selected four modes of action (MoAs)—CAR Ts, CPIs, BiTEs and IL-2 TREGs—needing …
First paper on “Immunocompetent cancer-on-chip models” published!
The advances in cancer immunotherapy come with several roadblocks limiting their widespread use and their …